Antiviral Drugs Against Hepatitis C Virus
Author Information
Author(s): Rehman Sidra, Ashfaq Usman A, Javed Tariq
Primary Institution: Division of Molecular Medicine, National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
Hypothesis
There is a need to develop antiviral agents from both synthetic chemistry and herbal sources to combat hepatitis C virus (HCV) infection.
Conclusion
Further innovative research on chemical compounds will lead to consistent standard therapy with fewer side effects for HCV.
Supporting Evidence
- HCV has infected 200 million people worldwide, with 10 million in Pakistan.
- Current treatments have significant side effects and slow response rates, especially in certain genotypes.
- Novel antiviral inhibitors have shown promising results in clinical trials.
Takeaway
This study looks at different medicines that can help fight the hepatitis C virus, which makes people sick. It suggests that combining new medicines with the usual treatments can work better and have fewer side effects.
Methodology
The review summarizes various antiviral compounds against HCV and discusses their activity in combination with standard therapy.
Limitations
The review does not provide specific clinical trial data or detailed statistical analyses of the compounds discussed.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website